AbbVie (ABBV) Current Assets (2012 - 2026)

AbbVie (ABBV) has reported Current Assets for 15 consecutive years, with $33.7 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Assets rose 15.06% year-over-year to $33.7 billion in Q2 2026; TTM through Jun 2026 was $33.7 billion, a 15.06% increase from a year earlier, with the FY2025 full-year figure at $29.1 billion, up 13.6% from the prior year.
• Current Assets was $33.7 billion for Q2 2026 at AbbVie, roughly flat from $33.5 billion in the prior quarter.
• Over five years, Current Assets peaked at $38.9 billion in Q1 2024 and troughed at $25.6 billion in Q4 2024.
• A 5-year average of $30.2 billion and a median of $29.1 billion in 2022 frame the typical range for Current Assets.
• Across the five-year window, Current Assets soared 46.75% in 2024 and retreated 28.8% in 2025, its largest moves.
• Over 5 years, Current Assets stood at $28.5 billion in 2022, then climbed by 15.95% to $33.0 billion in 2023, then fell by 22.48% to $25.6 billion in 2024, then grew by 13.6% to $29.1 billion in 2025, then increased by 15.85% to $33.7 billion in 2026.
• The last three Current Assets figures came in at $33.7 billion (Q2 2026), $33.5 billion (Q1 2026), and $29.1 billion (Q4 2025), per Business Quant data.